Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...
Can you leave a clinical trial early? Learn your rights, what happens if you withdraw, and how to exit safely without ...
An international research group has examined how many people are affected by preclinical and clinical obesity and what health ...
In the UK, wide‑ranging reforms coming into force on 28 April 2026 are designed to streamline approvals, embed a more ...
The National Institutes of Health will no longer categorize basic experimental studies involving humans (BESH) as clinical trials, according to a Jan. 29 announcement from the agency. BESH ...
This year's conference in Manchester brought the brightest minds together to discuss bold new ways to treat diagnose and prevent dementia.
New platform connects patients with licensed providers offering sermorelin under medical supervision, supported by a growing body of peer-reviewed research and an emerging community of clinicians and ...
A new peer-reviewed paper calls for meaning, purpose, and spirituality to be treated as core components of lifestyle medicine ...
Clinical Trials Arena on MSN
The clinical trial supply model of the future
With various challenges impacting the clinical supply chain, existing models are no longer fit-for-purpose and need to adapt.
Non-inferiority trials are a valuable type of clinical trial to evaluate new treatments that might have differing benefits. Such trials are increasingly used, but have methodological challenges in ...
ImmunityBio’s sBLA targets BCG-unresponsive papillary NMIBC without CIS, complementing the existing U.S. approval for CIS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results